Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The sigma-2 receptor (S2R), encoded by the TMEM97 gene, is an integral membrane protein primarily localized to the endoplasmic reticulum and lipid rafts. It plays a role in cholesterol homeostasis, modulates neuronal signaling, and is highly expressed in proliferating cells, including tumor cells. S2R has emerged as a promising therapeutic target for neurodegenerative diseases and cancer, with preclinical studies showing that small-molecule modulators can rescue impaired biological functions.
Small-molecule modulators targeting S2R can rescue impaired biological functions
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sigma-2 Receptor (S2R).